Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment.
about
Is high-dose leuprorelin acetate effective and safe in asian men with prostate cancer? An open-label, non-comparative, multi-center clinical trial.Translation and linguistic validation of the korean version of the dysfunctional voiding symptom score.Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26).The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population.Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea
P2860
Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development and validation of ...... ter prostate cancer treatment.
@en
Development and validation of ...... ter prostate cancer treatment.
@nl
type
label
Development and validation of ...... ter prostate cancer treatment.
@en
Development and validation of ...... ter prostate cancer treatment.
@nl
prefLabel
Development and validation of ...... ter prostate cancer treatment.
@en
Development and validation of ...... ter prostate cancer treatment.
@nl
P2093
P2860
P1476
Development and validation of ...... ter prostate cancer treatment.
@en
P2093
Deok Hyun Han
Jung Jun Kim
Kyung Jin Chung
Soo Hyun Lim
Sung Won Lee
Tae Heon Kim
P2860
P304
P356
10.4111/KJU.2010.51.9.601
P577
2010-09-16T00:00:00Z